SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001725160-21-000028
Filing Date
2021-02-10
Accepted
2021-02-10 09:41:12
Documents
2
Period of Report
2021-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161296805832437.html 3  
1 FORM 3 wf-form3_161296805832437.xml 3 1750
2 POWER OF ATTORNEY FOR ENOCH KARIUKI ex-24.htm EX-24 3211
  Complete submission text file 0001725160-21-000028.txt   6556
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, LLC 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Kariuki Enoch (Reporting) CIK: 0001843119 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39263 | Film No.: 21609657